MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Vial comparison
Compare Peptide 3 (R) listings by strength, selection and supplier. Inspect the original source behind each price.
MATCH SIZE AND QUANTITY
Choose a labeled amount and selection to load matching prices.
GO BEYOND THE PRICE
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Reported quantities in this family: 1, 10. Counts and units must be matched to the exact listing.
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 10 mg | 1 vial | $99.00 | $9.90 | 2 | Compare |
| 24 mg | 1 vial | $179.00 | $7.46 | 2 | Compare |
| 30 mg | 1 vial | $219.00 | $7.30 | 2 | Compare |
| 40 mg | 1 vial | $259.00 | $6.48 | 2 | Compare |
| 60 mg | 1 vial | $299.00 | $4.98 | 2 | Compare |
| 100 mg | 1 vial | $330.00 | $3.30 | 2 | Compare |

122 products · 249 listings

153 products · 275 listings
24 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
FROM PEPTIDES CALCULATOR
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Retatrutide (LY3437943) is an investigational once-weekly injectable peptide that activates the GIP, GLP-1 and glucagon receptors at the same time. It is a 39-amino-acid analog with two Aib residues, an alpha-methyl-leucine, a C-terminal amide and a C20 fatty diacid attached through a linker to lysine 17, which extends its half-life to roughly a week. In phase 2 it produced a mean weight loss of 24.2% at 48 weeks, and the phase 3 TRIUMPH program has reported 25-28% at 80 weeks; it remains investigational, with no approved label or dosing schedule.
The 48-week trial enrolled 338 adults and compared multiple weekly doses with placebo.
Gastrointestinal events were common and were partially mitigated by starting at 2 mg rather than 4 mg.
No approved retatrutide product or public prescribing schedule exists.
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.